Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suitsnews2022-07-29T17:08:24+00:00July 29th, 2022|The New York Times|
Cancer Drug Greatly Reduces Deaths in Hospitalized Covid Patientsnews2022-07-06T11:00:10+00:00July 6th, 2022|The New York Times|
En Brasil, las mujeres tienen que adquirir las píldoras abortivas de los narcotraficantesnews2022-06-29T07:00:13+00:00June 29th, 2022|The New York Times|
When Abortion Pills Were Banned in Brazil, Women Turned to Drug Traffickersnews2022-06-28T07:00:14+00:00June 28th, 2022|The New York Times|
Abortion Pills Take the Spotlight as States Impose Abortion Bansnews2022-06-26T07:00:11+00:00June 26th, 2022|The New York Times|
Trial of New Alzheimer’s Drug Reports Disappointing Resultsnews2022-06-16T22:25:55+00:00June 16th, 2022|The New York Times|
Abortion Pills Will Be the Next Battleground in a Post-Roe Americanews2022-05-06T01:16:08+00:00May 6th, 2022|The New York Times|
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drugnews2022-04-06T18:43:00+00:00April 6th, 2022|The New York Times|
New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Findsnews2022-03-30T22:45:15+00:00March 30th, 2022|The New York Times|
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risknews2022-03-23T20:29:21+00:00March 23rd, 2022|The New York Times|
